Pfizer (PFE) Stock Buyback History
TTM buyback yield N/A.
Pfizer
PFE
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
1.0%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 0.00x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | 5.69B | -0.2% | — |
| 2024 | $0.00 | $877.00M | −$877.00M | 5.70B | -0.2% | — |
| 2023 | $0.00 | $525.00M | −$525.00M | 5.71B | -0.4% | — |
| 2022 | $2.00B | $872.00M | $1.13B | 5.73B | 0.4% | 0.70% |
| 2021 | $0.00 | $1.18B | −$1.18B | 5.71B | 1.3% | — |
| 2020 | $0.00 | $756.00M | −$756.00M | 5.63B | -0.8% | — |
| 2019 | $8.87B | $718.00M | $8.15B | 5.67B | -5.1% | 4.31% |
| 2018 | $12.20B | $949.00M | $11.25B | 5.98B | -1.3% | 5.09% |
| 2017 | $5.00B | $840.00M | $4.16B | 6.06B | -1.6% | 2.44% |
| 2016 | $5.00B | $691.00M | $4.31B | 6.16B | -1.6% | 2.68% |
| 2015 | $6.16B | $669.00M | $5.49B | 6.26B | -2.6% | 3.26% |
| 2014 | $5.00B | $586.00M | $4.41B | 6.42B | -6.8% | 2.69% |
| 2013 | $16.29B | $523.00M | $15.77B | 6.89B | -8.2% | 8.71% |
| 2012 | $8.23B | $481.00M | $7.75B | 7.51B | -4.6% | 4.73% |
| 2011 | $9.00B | $419.00M | $8.58B | 7.87B | -2.5% | 5.75% |
| 2010 | $1.00B | $405.00M | $595.00M | 8.07B | 14.6% | 0.75% |
| 2009 | $0.00 | $349.00M | −$349.00M | 7.04B | 4.4% | — |
| 2008 | $500.00M | $0.00 | $500.00M | 6.75B | -2.7% | 0.44% |
| 2007 | $9.99B | $0.00 | $9.99B | 6.94B | -4.6% | 6.84% |
| 2006 | $6.98B | $0.00 | $6.98B | 7.27B | -1.8% | 3.98% |
| 2005 | $3.80B | $0.00 | $3.80B | 7.41B | -2.7% | 2.34% |
| 2004 | $6.66B | $0.00 | $6.66B | 7.61B | 4.5% | 3.50% |
| 2003 | $13.04B | $0.00 | $13.04B | 7.29B | 16.7% | 5.13% |
| 2002 | $5.00B | $0.00 | $5.00B | 6.24B | -1.9% | 2.82% |
| 2001 | $3.67B | $0.00 | $3.67B | 6.36B | -0.1% | 1.56% |
| 2000 | $1.00B | $0.00 | $1.00B | 6.37B | 0.8% | — |
| 1999 | $2.54B | $0.00 | $2.54B | 6.32B | 60.4% | — |
| 1998 | $2.18B | $0.00 | $2.18B | 3.94B | -0.3% | — |
| 1997 | $586.00M | $0.00 | $586.00M | 3.95B | 2.4% | — |
| 1996 | $27.00M | $0.00 | $27.00M | 3.86B | — | — |
| 1995 | $108.50M | $0.00 | $108.50M | — | — | — |
| 1994 | $511.20M | $0.00 | $511.20M | — | — | — |
| 1993 | $1.02B | $0.00 | $1.02B | — | — | — |
| 1992 | $665.10M | $0.00 | $665.10M | — | — | — |
| 1991 | $463.90M | $0.00 | $463.90M | — | — | — |
| 1990 | $132.20M | $0.00 | $132.20M | — | — | — |
| 1989 | $154.70M | $0.00 | $154.70M | — | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)N/A
Headroom $0.00 (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Pfizer buy back its own stock?
- Yes, Pfizer (PFE) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is Pfizer diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Pfizer's share count changed?
- Diluted weighted average shares changed by about 1.0% over roughly five fiscal years (annual income statement data).